Notable Announces $40M Series B Round to Fuel Development of Its Drug Discovery Platform for Personalized Oncology SAN FRANCISCO, July 16, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction of the...

Algernon Pharmaceuticals Announces Short Form Prospectus Unit Offering NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, British...

Algernon Pharmaceuticals Appoints Leading Liver Disease Expert Dr. Arun Sanyal to Its Medical and Scientific Advisory Board VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...

Oncology Startup Notable Labs Donates its First Pediatric Therapy to Repurposing Non-Profit FOSTER CITY, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Notable Labs, a startup that accelerates drug development by matching drugs with patients who are most likely to respond, announced today that...